Nuclear Medicine: Page 81

C-11-based PET tracer could benefit arthritis patients
By Wayne Forrest
Carbon-11 (C-11) PET that targets translocator protein expression in the joint lining tissue of the knee may be a better way to determine the extent of rheumatoid arthritis, according to a study published in the July issue of the Journal of Nuclear Medicine.
July 8, 2018
2018 07 09 20 58 3332 Jnm Narayan Pet Images 400
Time-of-flight PET can reduce radiation dose in pediatrics
By Wayne Forrest
By adding a time-of-flight technique to pediatric PET scans, clinicians can adjust radiation dose levels by as much as 50% with no discernible loss of diagnostic image quality, according to a study presented at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Philadelphia.
July 8, 2018
2018 07 06 22 01 6839 Snmmi Tof Petmri 20180706225233
Australian reactor woes worry nuclear medicine
By Brian Casey
The shutdown of shipments from a nuclear reactor in Australia that is a key part of the global supply network for the radioisotope molybdenum-99 is causing consternation in the nuclear medicine community, particularly in the Asia-Pacific region.
July 6, 2018
2016 09 13 17 07 43 134 Atomic Technology 400
ITG, Bruce Power team up on lutetium-177 production
By AuntMinnie.com staff writers
German firm Isotope Technologies Garching (ITG) and nuclear reactor operator Bruce Power have signed a memorandum of understanding for the joint production of the radioisotope lutetium-177.
July 5, 2018
Week in Review: Welcome to the trade war | Molybdenum woes | Risk-based breast screening
By Brian Casey
July 5, 2018
Can deep learning monitor lesions on F-18 NaF PET/CT?
By Erik L. Ridley
Deep learning can classify bone lesions found on F-18 sodium fluoride (NaF) PET/CT exams, potentially enabling monitoring of individual lesions and faster interpretation times, according to research presented recently at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Philadelphia.
July 4, 2018
2016 09 06 13 31 23 491 Question Mark Blue 400
Cardiac hybrid imaging predicts adverse cardiac events
By Abraham Kim
A cardiac hybrid imaging technique that fuses SPECT myocardial perfusion imaging with coronary CT angiography scans can help predict major adverse cardiac events in patients suspected of having coronary artery disease, according to a study published online July 3 in Radiology.
July 3, 2018
2018 07 03 16 22 0383 Cardiac Hybrid Image 20180703164402
Novel nanoSPECT/CT radionuclide could aid cancer therapy
By Wayne Forrest
Swedish and Dutch researchers are reporting early progress in combining nanoSPECT/CT with a novel pretargeted radionuclide therapy for cancer that so far is nontoxic to the kidneys, according to a preclinical study published in the July issue of the Journal of Nuclear Medicine.
July 2, 2018
2018 07 02 21 04 7999 Jnm Mice Nano Spect Ct Image 215
Alliance Medical Group acquires Piramal Imaging
By AuntMinnie.com staff writers
The Alliance Medical Group has reached an agreement to acquire Piramal Imaging, which includes its two subsidiaries -- Piramal Imaging Ltd. and Piramal Imaging GmbH -- and its U.S. business.
July 1, 2018
2018 07 02 17 03 9361 Piramal Thumbnail 400
Start-up to develop arthritis molecular imaging agent
By AuntMinnie.com staff writers
U.K. life sciences developer Serac Life Sciences has established a new company, Serac Healthcare, to develop a molecular imaging agent that will help rheumatologists manage treatment for their arthritis patients.
June 27, 2018
SNMMI: AI enables stress-first SPECT MPI protocol
By Erik L. Ridley
PHILADELPHIA - Artificial intelligence (AI) analysis of stress SPECT myocardial perfusion imaging (MPI) can be highly sensitive for all types of coronary artery disease, according to research presented Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2018
2016 09 20 16 53 46 654 Heart Scan 400
Live from SNMMI 2018: Update on radiopharmaceuticals
What's going on in the world of medical isotopes? From molybdenum supply to reimbursement, there is no lack of issues facing the Council for Radionuclides and Radiopharmaceuticals (CORAR). Michael Guastella, CORAR’s executive director, spoke with AuntMinnie.com Features Editor Wayne Forrest during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2018
2018 06 26 22 53 2124 Guastella Michael
Previous Page
Page 81 of 445
Next Page